Cystic Fibrosis Home > Zenpep and Breastfeeding
It is unknown if Zenpep (pancrelipase) passes through breast milk. However, this drug is approved for use in infants, which indicates it may be safe for use while breastfeeding. In many cases, the benefits to the breastfeeding woman using Zenpep would exceed the potential risks to a nursing infant.
Zenpep® (pancrelipase) is a prescription medication approved for the treatment of pancreatic enzyme deficiencies, such as the type of deficiency that occurs with cystic fibrosis. It is unknown whether Zenpep passes through breast milk in humans.
Zenpep has not been studied in any breastfeeding humans or animals. It is unknown if it passes through breast milk. However, keep in mind that the drug is approved for use in babies, which means it has demonstrated safety in infants. This suggests that it would probably be safe for use during breastfeeding.
Breastfeeding is a time of increased nutritional need for mothers, and it would not be a good time to leave a pancreatic digestive enzyme deficiency untreated, as it can lead to malnutrition. In many cases, the benefits for a woman to take Zenpep while breastfeeding exceed the potential risks to the nursing infant.
You should discuss breastfeeding and Zenpep use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.